Description
Recombinant monoclonal antibody to FGF13/FHF2. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma N91/27.1. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.
Target
FGF13/FHF2
Target Alias Names
N91/27.1R, Fibroblast growth factor 13, FGF-13, Fibroblast growth factor homologous factor 2, FHF-2
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression